R. Vega-Bravo

DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

Javier Martínez‐Useros, María Rodríguez‐Remírez, Aurea Borrero‐Palacios et al. · BMC Cancer · 2014 · 25 citations · Full text

Medicine, Cancer Biology, Oncology +14

Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer

Teresa Gómez del Pulgar, Arancha Cebrián, María Jesús Fernández‐Aceñero et al. · Journal of Cellular and Molecular Medicine · 2016 · 20 citations · Full text

Medicine, Oncology, Surgery +17

Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy

Arancha Cebrián, Teresa Gómez del Pulgar, María Jesús Fernández‐Aceñero et al. · Pathology - Research and Practice · 2016 · 17 citations

Medicine, Cancer Biology, Oncology +16

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

Aurea Borrero‐Palacios, Arancha Cebrián, María Teresa Gómez del Pulgar et al. · Scientific Reports · 2019 · 11 citations · Full text

Medicine, Immunology, Oncology +17